• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于耐药性与节拍化疗:一种数学建模与最优控制方法。

On drug resistance and metronomic chemotherapy: A mathematical modeling and optimal control approach.

作者信息

Ledzewicz Urszula, Wang Shuo, Schattler Heinz, Andre Nicolas, Heng Marie Amelie, Pasquier Eddy

机构信息

Institute of Mathematics, Lodz University of Technology, 90-924 Lodz, Poland. email:

出版信息

Math Biosci Eng. 2017 Feb 1;14(1):217-235. doi: 10.3934/mbe.2017014.

DOI:10.3934/mbe.2017014
PMID:27879129
Abstract

Effects that tumor heterogeneity and drug resistance have on the structure of chemotherapy protocols are discussed from a mathematical modeling and optimal control point of view. In the case when two compartments consisting of sensitive and resistant cells are considered, optimal protocols consist of full dose chemotherapy as long as the relative proportion of sensitive cells is high. When resistant cells become more dominant, optimal controls switch to lower dose regimens defined by so-called singular controls. The role that singular controls play in the structure of optimal therapy protocols for cell populations with a large number of traits is explored in mathematical models.

摘要

从数学建模和最优控制的角度讨论了肿瘤异质性和耐药性对化疗方案结构的影响。在考虑由敏感细胞和耐药细胞组成的两个区室的情况下,只要敏感细胞的相对比例较高,最优方案就包括全剂量化疗。当耐药细胞变得更占优势时,最优控制切换到由所谓的奇异控制定义的较低剂量方案。在数学模型中探讨了奇异控制在具有大量特征的细胞群体的最优治疗方案结构中所起的作用。

相似文献

1
On drug resistance and metronomic chemotherapy: A mathematical modeling and optimal control approach.关于耐药性与节拍化疗:一种数学建模与最优控制方法。
Math Biosci Eng. 2017 Feb 1;14(1):217-235. doi: 10.3934/mbe.2017014.
2
Application of mathematical models to metronomic chemotherapy: What can be inferred from minimal parameterized models?数学模型在节律性化疗中的应用:从最小参数化模型中可以推断出什么?
Cancer Lett. 2017 Aug 10;401:74-80. doi: 10.1016/j.canlet.2017.03.021. Epub 2017 Mar 18.
3
Angiogenesis and chemotherapy resistance: optimizing chemotherapy scheduling using mathematical modeling.血管生成与化疗耐药:利用数学建模优化化疗方案。
J Cancer Res Clin Oncol. 2021 Aug;147(8):2281-2299. doi: 10.1007/s00432-021-03657-9. Epub 2021 May 29.
4
Optimal control of a mathematical model for cancer chemotherapy under tumor heterogeneity.肿瘤异质性下癌症化疗数学模型的最优控制
Math Biosci Eng. 2016 Dec 1;13(6):1223-1240. doi: 10.3934/mbe.2016040.
5
ATP-binding cassette transporters in tumor endothelial cells and resistance to metronomic chemotherapy.肿瘤内皮细胞中的三磷酸腺苷结合盒转运蛋白与节拍式化疗耐药性。
Cancer Lett. 2017 Aug 1;400:305-310. doi: 10.1016/j.canlet.2017.02.006. Epub 2017 Feb 16.
6
Optimization of an in vitro chemotherapy to avoid resistant tumours.优化体外化疗以避免产生耐药肿瘤。
J Theor Biol. 2017 Jan 21;413:24-33. doi: 10.1016/j.jtbi.2016.11.009. Epub 2016 Nov 15.
7
Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer.节拍化疗可提高卵巢癌抗血管生成治疗的疗效。
Cancer Res. 2007 Jan 1;67(1):281-8. doi: 10.1158/0008-5472.CAN-06-3282.
8
What does not kill a tumour may make it stronger: In silico insights into chemotherapeutic drug resistance.未杀死肿瘤的物质可能使其更强:化疗耐药性的计算洞察。
J Theor Biol. 2018 Oct 7;454:253-267. doi: 10.1016/j.jtbi.2018.06.014. Epub 2018 Jun 15.
9
Adaptive therapy.适应性疗法
Cancer Res. 2009 Jun 1;69(11):4894-903. doi: 10.1158/0008-5472.CAN-08-3658.
10
Calculated resistance in cancer.癌症中的计算电阻。
Nat Med. 2005 Aug;11(8):824-5. doi: 10.1038/nm0805-824.

引用本文的文献

1
Strategies to Reduce Long-Term Drug Resistance by Considering Effects of Differential Selective Treatments.通过考虑差异选择性治疗的效果来降低长期耐药性的策略。
Math Comput Oncol (2021). 2021;13060:49-60. doi: 10.1007/978-3-030-91241-3_5. Epub 2021 Dec 12.
2
Effective dose window for containing tumor burden under tolerable level.可耐受水平下控制肿瘤负荷的有效剂量窗口。
NPJ Syst Biol Appl. 2023 May 23;9(1):17. doi: 10.1038/s41540-023-00279-4.
3
Normalizing tumor microenvironment with nanomedicine and metronomic therapy to improve immunotherapy.
利用纳米医学和节拍疗法使肿瘤微环境正常化以改善免疫疗法。
J Control Release. 2022 May;345:190-199. doi: 10.1016/j.jconrel.2022.03.008. Epub 2022 Mar 8.
4
Optimal regulation of tumour-associated neutrophils in cancer progression.肿瘤相关中性粒细胞在癌症进展中的最佳调控
R Soc Open Sci. 2022 Feb 2;9(2):210705. doi: 10.1098/rsos.210705. eCollection 2022 Feb.
5
Do mechanisms matter? Comparing cancer treatment strategies across mathematical models and outcome objectives.机制重要吗?比较数学模型和结果目标下的癌症治疗策略。
Math Biosci Eng. 2021 Jul 21;18(5):6305-6327. doi: 10.3934/mbe.2021315.
6
Her2-Targeted Multifunctional Nano-Theranostic Platform Mediates Tumor Microenvironment Remodeling and Immune Activation for Breast Cancer Treatment.针对 Her2 的多功能纳米诊疗平台通过重塑肿瘤微环境和激活免疫来治疗乳腺癌。
Int J Nanomedicine. 2020 Dec 9;15:10007-10028. doi: 10.2147/IJN.S271213. eCollection 2020.
7
Impact of Cisplatin Dosing Regimens on Mammary Tumor Growth in an Animal Model.顺铂给药方案对动物模型中乳腺肿瘤生长的影响
Arch Cancer Biol Ther. 2020;1(1):18-21. doi: 10.33696/cancerbiology.1.004. Epub 2020 Jun 15.
8
A Review of Mathematical Models for Tumor Dynamics and Treatment Resistance Evolution of Solid Tumors.实体瘤肿瘤动力学和治疗抵抗性演变的数学模型综述
CPT Pharmacometrics Syst Pharmacol. 2019 Oct;8(10):720-737. doi: 10.1002/psp4.12450. Epub 2019 Aug 9.
9
Capitalizing on competition: An evolutionary model of competitive release in metastatic castration resistant prostate cancer treatment.利用竞争:转移性去势抵抗性前列腺癌治疗中竞争释放的进化模型。
J Theor Biol. 2018 Oct 14;455:249-260. doi: 10.1016/j.jtbi.2018.07.028. Epub 2018 Jul 23.